Advanced company searchLink opens in new window

MIRZYME THERAPEUTICS LIMITED

Company number 10133310

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Jan 2019 AA Total exemption full accounts made up to 30 April 2018
14 Nov 2018 AP01 Appointment of Michael Edwin Vousden as a director on 3 October 2018
10 Oct 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
02 Oct 2018 SH01 Statement of capital following an allotment of shares on 14 September 2018
  • GBP 100.06
02 Oct 2018 SH01 Statement of capital following an allotment of shares on 25 July 2018
  • GBP 100.036
  • ANNOTATION Clarification a second filed SH01 was registered on 04/05/2023.
13 Sep 2018 AP01 Appointment of Dr Syed Omar Hayat as a director on 1 September 2018
22 Apr 2018 CS01 Confirmation statement made on 18 April 2018 with updates
07 Mar 2018 SH02 Sub-division of shares on 30 October 2017
18 Jan 2018 AA Accounts for a dormant company made up to 30 April 2017
23 Oct 2017 AD01 Registered office address changed from C/O Prof Asif Ahmed Aston Medical School, Aston University, Birmingham, B4 7ET United Kingdom to Faraday Wharf, Innovation Birmingham Campus Holt Street Birmingham West Midlands B7 4BB on 23 October 2017
27 Apr 2017 CS01 Confirmation statement made on 18 April 2017 with updates
19 Apr 2016 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2016-04-19
  • GBP 100